The Hydration Pharmaceuticals Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HPC.AX research report →
Price Chart
About the company
The Hydration Pharmaceuticals Company Limited, established in 2001, provides a diverse portfolio of healthy hydration remedies, offered as liquids, tablets, and powders. Operating from its headquarters in San Diego, California, the company distributes these Hydralyte-branded items through both conventional retail outlets and digital e-commerce platforms across Australia, the United States, and Canada.
- CEO
- Oliver Baker
- IPO
- 2021
- Employees
- 3
- HQ
- Melbourne, VIC, AU
Get TickerSpark's AI analysis on HPC.AX
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.06M
- P/E
- -0.50
- PEG
- 0.00
- P/S
- 0.59
- P/B
- 1.09
- EV/EBITDA
- -0.09
- Div Yield
- 0.00%
- Gross Margin
- 32.86%
- Op Margin
- -127.49%
- Net Margin
- -115.99%
- ROE
- -139.90%
- ROIC
- -223.51%
Latest fiscal year · YoY change
- Revenue
- $2.56M-20.2%
- Gross Profit
- $-27,419-101.7%
- Op Income
- $-3,255,916
- Net Income
- $-2,960,661-211.0%
- EPS
- $-0.01-136.2%
- OCF Growth
- -25.2%
- FCF Growth
- -25.2%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.97
- RSI (14)
- 91
- Avg Volume
- 345.80K
No earnings-call transcripts are available for HPC.AX yet.
- Free Float
- 90.0%
- Shares Outstanding
- 411.96M
- Float Shares
- 370.84M
Our HPC.AX coverage
Recent articles, reports, and earnings notes.
No research on HPC.AX yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HPC.AX report →